Catalyst Funds Management’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-4,800	Closed	-$241K	–	1430
2024 Q1	$241K	Buy	+4,800	New	+$241K	0.07%	223